PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1984 December; 77(12): 998–1001.
PMCID: PMC1440159

Antiviral treatment of chronic hepatitis B virus infection.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (657K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bassendine MF, Chadwick RG, Salmeron J, Shipton U, Thomas HC, Sherlock S. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study. Gastroenterology. 1981 May;80(5 Pt 1):1016–1022. [PubMed]
  • Chadwick RG, Bassendine MF, Crawford EM, Thomas HC, Sherlock S. HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine. Br Med J. 1978 Aug 19;2(6136):531–533. [PMC free article] [PubMed]
  • Dolei A, Capobianchi MR, Ameglio F. Human interferon-gamma enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively than interferon-alpha and interferon-beta. Infect Immun. 1983 Apr;40(1):172–176. [PMC free article] [PubMed]
  • Fyfe JA, Keller PM, Furman PA, Miller RL, Elion GB. Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine. J Biol Chem. 1978 Dec 25;253(24):8721–8727. [PubMed]
  • Hoofnagle JH, Hanson RG, Minuk GY, Pappas SC, Schafer DF, Dusheiko GM, Straus SE, Popper H, Jones EA. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis. Gastroenterology. 1984 Jan;86(1):150–157. [PubMed]
  • Liaw YF, Chu CM, Su IJ, Huang MJ, Lin DY, Chang-Chien CS. Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis. Gastroenterology. 1983 Feb;84(2):216–219. [PubMed]
  • Lok AS, Weller IV, Karayiannis P, Brown D, Fowler MJ, Monjardino J, Thomas HC, Sherlock S. Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication. Liver. 1984 Feb;4(1):45–49. [PubMed]
  • The British Society of Gastroenterology. 25-27 April 1984, Salford. Abstracts. Gut. 1984 May;25(5):A541–A585. [PMC free article] [PubMed]
  • Novick DM, Lok AS, Thomas HC. Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease. J Hepatol. 1985;1(1):29–35. [PubMed]
  • Perrillo RP, Campbell CR, Sanders GE, Regenstein FG, Bodicky CJ. Spontaneous clearance and reactivation of hepatitis B virus infection among male homosexuals with chronic type B hepatitis. Ann Intern Med. 1984 Jan;100(1):43–46. [PubMed]
  • Rizzetto M. The delta agent. Hepatology. 1983 Sep-Oct;3(5):729–737. [PubMed]
  • Scullard GH, Pollard RB, Smith JL, Sacks SL, Gregory PB, Robinson WS, Merigan TC. Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside. J Infect Dis. 1981 Jun;143(6):772–783. [PubMed]
  • Smith CI, Weissberg J, Bernhardt L, Gregory PB, Robinson WS, Merigan TC. Acute Dane particle suppression with recombinant leukocyte A interferon in chronic hepatitis B virus infection. J Infect Dis. 1983 Nov;148(5):907–913. [PubMed]
  • Viola LA, Barrison IG, Coleman JC, Paradinas FJ, Fluker JL, Evans BA, Murray-Lyon IM. Natural history of liver disease in chronic hepatitis B surface antigen carriers. Survey of 100 patients from Great Britain. Lancet. 1981 Nov 21;2(8256):1156–1159. [PubMed]
  • Weimar W, Heijtink RA, Schalm SW, Schellekens H. Differential effects of fibroblast and leucocyte interferon in HBsAg positive chronic active hepatitis. Eur J Clin Invest. 1979 Apr;9(2 Pt 1):151–154. [PubMed]
  • Weimar W, Heijtink RA, ten Kate FJ, Schalm SW, Masurel N, Schellekens H, Cantell K. Double-blind study of leucocyte interferon administration in chronic HBsAg-positive hepatitis. Lancet. 1980 Feb 16;1(8164):336–338. [PubMed]
  • Weller IV, Bassendine MF, Craxi A, Fowler MJ, Monjardino J, Thomas HC, Sherlock S. Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP). Gut. 1982 Sep;23(9):717–723. [PMC free article] [PubMed]
  • Weller IV, Bassendine MF, Murray AK, Craxi A, Thomas HC, Sherlock S. Effects of prednisolone/azathioprine in chronic hepatitis B viral infection. Gut. 1982 Aug;23(8):650–655. [PMC free article] [PubMed]
  • Weller IV, Carreno V, Fowler MJ, Monjardino J, Makinen D, Varghese Z, Sweny P, Thomas HC, Sherlock S. Acyclovir in hepatitis B antigen-positive chronic liver disease: inhibition of viral replication and transient renal impairment with iv bolus administration. J Antimicrob Chemother. 1983 Mar;11(3):223–231. [PubMed]
  • Weller IV, Karayiannis P, Lok AS, Montano L, Bamber M, Thomas HC, Sherlock S. Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers. Gut. 1983 Nov;24(11):1061–1063. [PMC free article] [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press